866-997-4948(US-Canada Toll Free)

Global and China Live Attenuated Vaccine Industry Professional Market Report 2017

Published By :

QYResearch

Published Date : Aug 2017

Category :

Pharmaceutical

No. of Pages : 112 Pages

This report splits Live Attenuated Vaccine market By End User, By Disease Indication, which shares the history data information from 2012 to 2016 and forecast from 2017 to 2022.

This report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details.

This report focus Global and China market, coving details as following:
Key Players
Astellas Pharma (Japan)
CSL Limited (Australia)
Emergent BioSolutions (U.S.)
GlaxoSmithKline (U.K.)
Johnson & Johnson (U.S.)
MedImmune (U.S.)
Merck & Co (U.S.)
Pfizer (U.S.)
Sanofi Pasteur (France)
Serum Institute of India Pvt (India)

Key Regions
Asia Pacific
China
First-tier Cities
Second-tier Cities
Third-tier Cities
Others
Japan
Korea
India
Others
Europe
France
Germany
United Kingdom
Italy
Russia
Others
North America
United States
Canada
Latin America
Brazil
Mexico
Others
Southeast Asia
Singapore
Malaysia
Vietnam
Myanmar
Thailand
Indonesia
Philippines
Others
Middle East & Africa
Saudi Arabia
Iran
UAE
Turkey
Israel
Egypt
South Africa
Others

Key Product Type
Live Attenuated Vaccine Market, by End User
Pediatrics
Adults
Live Attenuated Vaccine Market, by Disease Indication
Pneumococcal
Influenza
HPV
Hepatitis
Rotavirus

Key Consumers (End User)
Hospital
Medical Center
Others
Table of Contents

Global and China Live Attenuated Vaccine Industry Professional Market Report 2017
Chapter One Global and China Live Attenuated Vaccine Market Overview
1.1 China Live Attenuated Vaccine Market Sales Volume Revenue and Price 2012-2017
1.2 Global Live Attenuated Vaccine Market Sales Volume Revenue and Price 2012-2017
1.3 Global and China Live Attenuated Vaccine, by End User 2012-2017
1.3.1 China Live Attenuated Vaccine Sales Market Share by End User 2012-2017
1.3.2 Global Live Attenuated Vaccine Sales Market Share by End User 2012-2017
1.3.3 China Live Attenuated Vaccine Revenue Market Share by End User 2012-2017
1.3.4 Global Live Attenuated Vaccine Revenue Market Share by End User 2012-2017
1.3.5 China Live Attenuated Vaccine Price by End User 2012-2017
1.3.6 Global Live Attenuated Vaccine Price by End User 2012-2017
1.3.7 Pediatrics
1.3.8 Adults
1.4 Global and China Live Attenuated Vaccine, by Disease Indication 2012-2017
1.4.1 China Live Attenuated Vaccine Sales Market Share by Disease Indication 2012-2017
1.4.2 Global Live Attenuated Vaccine Sales Market Share by Disease Indication 2012-2017
1.4.3 China Live Attenuated Vaccine Revenue Market Share by Disease Indication 2012-2017
1.4.4 Global Live Attenuated Vaccine Revenue Market Share by Disease Indication 2012-2017
1.4.5 China Live Attenuated Vaccine Price by Disease Indication 2012-2017
1.4.6 Global Live Attenuated Vaccine Price by Disease Indication 2012-2017
1.4.7 Pneumococcal
1.4.8 Influenza
1.4.9 HPV
1.4.10 Hepatitis
1.4.11 Rotavirus

Chapter Two China Live Attenuated Vaccine Market by Regions 2012-2017
2.1 China Live Attenuated Vaccine Sales Market Share by Regions 2012-2017
2.2 China Live Attenuated Vaccine Revenue Market Share by Regions 2012-2017
2.3 China Live Attenuated Vaccine Price by Regions 2012-2017
2.4 First-tier Cities
2.5 Second-tier Cities
2.6 Third-tier Cities
2.7 Other Regions

Chapter Three Global Live Attenuated Vaccine Market by Regions 2012-2017
3.1 Global Live Attenuated Vaccine Sales Market Share by Regions 2012-2017
3.2 Global Live Attenuated Vaccine Revenue Market Share by Regions 2012-2017
3.3 Global Live Attenuated Vaccine Price by Regions 2012-2017
3.4 Asia Pacific
3.4.1 China
3.4.2 Japan
3.4.3 Korea
3.4.4 India
3.4.5 Others
3.5 Europe
3.5.1 Germany
3.5.2 United Kingdom
3.5.3 France
3.5.4 Italy
3.5.5 Russia
3.5.6 Others
3.6 North America
3.6.1 United States
3.6.2 Canada
3.7 Latin America
3.7.1 Brazil
3.7.2 Mexico
3.7.3 Others
3.8 Southeast Asia
3.8.1 Singapore
3.8.2 Malaysia
3.8.3 Vietnam
3.8.4 Myanmar
3.8.5 Thailand
3.8.6 Indonesia
3.8.7 Philippines
3.8.8 Others
3.9 Middle East & Africa
3.9.1 Saudi Arabia
3.9.2 Iran
3.9.3 UAE
3.9.4 Turkey
3.9.5 Israel
3.9.6 Egypt
3.9.7 South Africa
3.9.8 Others

Chapter Four Live Attenuated Vaccine by Players 2012-2017
4.1 China Live Attenuated Vaccine Sales Volume Market Share by Players 2012-2017
4.2 China Live Attenuated Vaccine Revenue Share by Players 2012-2017
4.3 China Top Players Live Attenuated Vaccine Key Product Model and Market Performance
4.4 China Top Players Live Attenuated Vaccine Key Target Consumers and Market Performance

Chapter Five Top Players Profile
5.1 Astellas Pharma (Japan)
5.1.1 Astellas Pharma (Japan) Company Details and Competitors
5.1.2 Astellas Pharma (Japan) Key Live Attenuated Vaccine Models and Performance
5.1.3 Astellas Pharma (Japan) Live Attenuated Vaccine Business SWOT Analysis and Forecast
5.1.4 Astellas Pharma (Japan) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
5.2 CSL Limited (Australia)
5.2.1 CSL Limited (Australia) Company Details and Competitors
5.2.2 CSL Limited (Australia) Key Live Attenuated Vaccine Models and Performance
5.2.3 CSL Limited (Australia) Live Attenuated Vaccine Business SWOT Analysis and Forecast
5.2.4 CSL Limited (Australia) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
5.3 Emergent BioSolutions (U.S.)
5.3.1 Emergent BioSolutions (U.S.) Company Details and Competitors
5.3.2 Emergent BioSolutions (U.S.) Key Live Attenuated Vaccine Models and Performance
5.3.3 Emergent BioSolutions (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
5.3.4 Emergent BioSolutions (U.S.) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
5.4 GlaxoSmithKline (U.K.)
5.4.1 GlaxoSmithKline (U.K.) Company Details and Competitors
5.4.2 GlaxoSmithKline (U.K.) Key Live Attenuated Vaccine Models and Performance
5.4.3 GlaxoSmithKline (U.K.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
5.4.4 GlaxoSmithKline (U.K.) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
5.5 Johnson & Johnson (U.S.)
5.5.1 Johnson & Johnson (U.S.) Company Details and Competitors
5.5.2 Johnson & Johnson (U.S.) Key Live Attenuated Vaccine Models and Performance
5.5.3 Johnson & Johnson (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
5.5.4 Johnson & Johnson (U.S.) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
5.6 MedImmune (U.S.)
5.6.1 MedImmune (U.S.) Company Details and Competitors
5.6.2 MedImmune (U.S.) Key Live Attenuated Vaccine Models and Performance
5.6.3 MedImmune (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
5.6.4 MedImmune (U.S.) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
5.7 Merck & Co (U.S.)
5.7.1 Merck & Co (U.S.) Company Details and Competitors
5.7.2 Merck & Co (U.S.) Key Live Attenuated Vaccine Models and Performance
5.7.3 Merck & Co (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
5.7.4 Merck & Co (U.S.) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
5.8 Pfizer (U.S.)
5.8.1 Pfizer (U.S.) Company Details and Competitors
5.8.2 Pfizer (U.S.) Key Live Attenuated Vaccine Models and Performance
5.8.3 Pfizer (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
5.8.4 Pfizer (U.S.) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
5.9 Sanofi Pasteur (France)
5.9.1 Sanofi Pasteur (France) Company Details and Competitors
5.9.2 Sanofi Pasteur (France) Key Live Attenuated Vaccine Models and Performance
5.9.3 Sanofi Pasteur (France) Live Attenuated Vaccine Business SWOT Analysis and Forecast
5.9.4 Sanofi Pasteur (France) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
5.10 Serum Institute of India Pvt (India)
5.10.1 Serum Institute of India Pvt (India) Company Details and Competitors
5.10.2 Serum Institute of India Pvt (India) Key Live Attenuated Vaccine Models and Performance
5.10.3 Serum Institute of India Pvt (India) Live Attenuated Vaccine Business SWOT Analysis and Forecast
5.10.4 Serum Institute of India Pvt (India) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin

Chapter Six Live Attenuated Vaccine by Consumer 2012-2017
6.1 China Live Attenuated Vaccine Sales Market Share by Consumer 2012-2017
6.2 Global Live Attenuated Vaccine Sales Market Share by Consumer 2012-2017
6.3 Hospital
6.4 Medical Center
6.5 Others
6.6 Consuming Habit and Preference

Chapter Seven Global and China Live Attenuated Vaccine Market Size (Sales and Revenue) Forecast (2017-2022)
7.1 Global and China Live Attenuated Vaccine Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
7.1.1 China Live Attenuated Vaccine Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
7.1.2 Global Live Attenuated Vaccine Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
7.2 Global and China Live Attenuated Vaccine Sales (K Pcs) Forecast by Type (2017-2022)
7.2.1 by By End User
7.2.2 by By Disease Indication
7.2.3 by
7.2.4 by
7.2.5 by
7.3 Global and China Live Attenuated Vaccine Sales (K Pcs) Forecast by Application (2017-2022)
7.4 Global and China Live Attenuated Vaccine Sales (K Pcs) Forecast by Regions (2017-2022)

Chapter Eight Industry Chain and Supply Chain
8.1 Live Attenuated Vaccine Industry Chain Structure
8.1.1 R&D
8.1.2 Raw Materials (Components)
8.1.3 Manufacturing Plants
8.1.4 Regional Trading (Import Export and Local Sales)
8.1.5 Online Sales Channel
8.1.6 Offline Channel
8.1.7 End Users
8.2 Live Attenuated Vaccine Manufacturing
8.2.1 Key Components
8.2.2 Assembly Manufacturing
8.3 Consumer Preference
8.4 Behavioral Habits
8.5 Marketing Environment

Chapter Nine Development Trend and Research Conclusion
9.1 Development Trend
9.2 Research Conclusion

Chapter Ten Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Disclaimer

List of Table

List of Tables and Figures

Table China Live Attenuated Vaccine Sales Volume (K Pcs), Revenue (Million USD) and Price (USD/Pcs)(2012-2017)
Figure China Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Live Attenuated Vaccine Sales Volume (K Pcs) and Growth Rate (2012-2017)
Table Global Live Attenuated Vaccine Sales Volume (K Pcs), Revenue (Million USD) and Price (USD/Pcs)(2012-2017)
Figure Global Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Global Live Attenuated Vaccine Sales Volume (K Pcs) and Growth Rate (2012-2017)
Table China Live Attenuated Vaccine Sales (K Pcs) by End User (2012-2017)
Table China Live Attenuated Vaccine Sales Market Share by End User (2012-2017)
Figure China Live Attenuated Vaccine Sales Market Share by End User in 2016
Table Global Live Attenuated Vaccine Sales (K Pcs) by End User (2012-2017)
Table Global Live Attenuated Vaccine Sales Market Share by End User (2012-2017)
Figure Global Live Attenuated Vaccine Sales Market Share by End User in 2016
Table China Live Attenuated Vaccine Revenue (Million USD) by End User (2012-2017)
Table China Live Attenuated Vaccine Revenue Market Share by End User (2012-2017)
Figure China Live Attenuated Vaccine Revenue Market Share by End User in 2016
Table Global Live Attenuated Vaccine Revenue (Million USD) by End User (2012-2017)
Table Global Live Attenuated Vaccine Revenue Market Share by End User (2012-2017)
Figure Global Live Attenuated Vaccine Revenue Market Share by End User in 2016
Table China Live Attenuated Vaccine Price (USD/Pcs) by End User (2012-2017)
Table Global Live Attenuated Vaccine Price (USD/Pcs) by End User (2012-2017)
Figure China Pediatrics Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Global Pediatrics Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Adults Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Global Adults Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Table China Live Attenuated Vaccine Sales (K Pcs) by Disease Indication (2012-2017)
Table China Live Attenuated Vaccine Sales Market Share by Disease Indication (2012-2017)
Figure China Live Attenuated Vaccine Sales Market Share by Disease Indication in 2016
Table Global Live Attenuated Vaccine Sales (K Pcs) by Disease Indication (2012-2017)
Table Global Live Attenuated Vaccine Sales Market Share by Disease Indication (2012-2017)
Figure Global Live Attenuated Vaccine Sales Market Share by Disease Indication in 2016
Table China Live Attenuated Vaccine Revenue (Million USD) by Disease Indication (2012-2017)
Table China Live Attenuated Vaccine Revenue Market Share by Disease Indication (2012-2017)
Figure China Live Attenuated Vaccine Revenue Market Share by Disease Indication in 2016
Table Global Live Attenuated Vaccine Revenue (Million USD) by Disease Indication (2012-2017)
Table Global Live Attenuated Vaccine Revenue Market Share by Disease Indication (2012-2017)
Figure Global Live Attenuated Vaccine Revenue Market Share by Disease Indication in 2016
Table China Live Attenuated Vaccine Price (USD/Pcs) by Disease Indication (2012-2017)
Table Global Live Attenuated Vaccine Price (USD/Pcs) by Disease Indication (2012-2017)
Figure China Pneumococcal Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Global Pneumococcal Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Influenza Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Global Influenza Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure China HPV Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Global HPV Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Hepatitis Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Global Hepatitis Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Rotavirus Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Global Rotavirus Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Table China Live Attenuated Vaccine Sales (K Pcs) by (2012-2017)
Table China Live Attenuated Vaccine Sales Market Share by (2012-2017)
Figure China Live Attenuated Vaccine Sales Market Share by in 2016
Table Global Live Attenuated Vaccine Sales (K Pcs) by (2012-2017)
Table Global Live Attenuated Vaccine Sales Market Share by (2012-2017)
Figure Global Live Attenuated Vaccine Sales Market Share by in 2016
Table China Live Attenuated Vaccine Revenue (Million USD) by (2012-2017)
Table China Live Attenuated Vaccine Revenue Market Share by (2012-2017)
Figure China Live Attenuated Vaccine Revenue Market Share by in 2016
Table Global Live Attenuated Vaccine Revenue (Million USD) by (2012-2017)
Table Global Live Attenuated Vaccine Revenue Market Share by (2012-2017)
Figure Global Live Attenuated Vaccine Revenue Market Share by in 2016
Table China Live Attenuated Vaccine Price (USD/Pcs) by (2012-2017)
Table Global Live Attenuated Vaccine Price (USD/Pcs) by (2012-2017)
Table China Live Attenuated Vaccine Sales (K Pcs) by (2012-2017)
Table China Live Attenuated Vaccine Sales Market Share by (2012-2017)
Figure China Live Attenuated Vaccine Sales Market Share by in 2016
Table Global Live Attenuated Vaccine Sales (K Pcs) by (2012-2017)
Table Global Live Attenuated Vaccine Sales Market Share by (2012-2017)
Figure Global Live Attenuated Vaccine Sales Market Share by in 2016
Table China Live Attenuated Vaccine Revenue (Million USD) by (2012-2017)
Table China Live Attenuated Vaccine Revenue Market Share by (2012-2017)
Figure China Live Attenuated Vaccine Revenue Market Share by in 2016
Table Global Live Attenuated Vaccine Revenue (Million USD) by (2012-2017)
Table Global Live Attenuated Vaccine Revenue Market Share by (2012-2017)
Figure Global Live Attenuated Vaccine Revenue Market Share by in 2016
Table China Live Attenuated Vaccine Price (USD/Pcs) by (2012-2017)
Table Global Live Attenuated Vaccine Price (USD/Pcs) by (2012-2017)
Table China Live Attenuated Vaccine Sales (K Pcs) by (2012-2017)
Table China Live Attenuated Vaccine Sales Market Share by (2012-2017)
Figure China Live Attenuated Vaccine Sales Market Share by in 2016
Table Global Live Attenuated Vaccine Sales (K Pcs) by (2012-2017)
Table Global Live Attenuated Vaccine Sales Market Share by (2012-2017)
Figure Global Live Attenuated Vaccine Sales Market Share by in 2016
Table China Live Attenuated Vaccine Revenue (Million USD) by (2012-2017)
Table China Live Attenuated Vaccine Revenue Market Share by (2012-2017)
Figure China Live Attenuated Vaccine Revenue Market Share by in 2016
Table Global Live Attenuated Vaccine Revenue (Million USD) by (2012-2017)
Table Global Live Attenuated Vaccine Revenue Market Share by (2012-2017)
Figure Global Live Attenuated Vaccine Revenue Market Share by in 2016
Table China Live Attenuated Vaccine Price (USD/Pcs) by (2012-2017)
Table Global Live Attenuated Vaccine Price (USD/Pcs) by (2012-2017)
Table China Live Attenuated Vaccine Sales (K Pcs) by Regions (2012-2017)
Table China Live Attenuated Vaccine Sales Share by Regions (2012-2017)
Figure China Live Attenuated Vaccine Sales Market Share by Regions in 2016
Figure China Live Attenuated Vaccine Sales Market Share by Regions in 2017
Table China Live Attenuated Vaccine Revenue (Million USD) and Market Share by Regions (2012-2017)
Table China Live Attenuated Vaccine Revenue Market Share by Regions (2012-2017)
Figure China Live Attenuated Vaccine Revenue Market Share by Regions in 2016
Figure China Live Attenuated Vaccine Revenue Market Share by Regions in 2017
Table China Live Attenuated Vaccine Price (USD/Pcs) by Regions (2012-2017)
Table Global Live Attenuated Vaccine Sales (K Pcs) by Regions (2012-2017)
Table Global Live Attenuated Vaccine Sales Share by Regions (2012-2017)
Figure Global Live Attenuated Vaccine Sales Market Share by Regions in 2016
Figure Global Live Attenuated Vaccine Sales Market Share by Regions in 2017
Table Global Live Attenuated Vaccine Revenue (Million USD) and Market Share by Regions (2012-2017)
Table Global Live Attenuated Vaccine Revenue Market Share by Regions (2012-2017)
Figure Global Live Attenuated Vaccine Revenue Market Share by Regions in 2016
Figure Global Live Attenuated Vaccine Revenue Market Share by Regions in 2017
Table Global Live Attenuated Vaccine Price (USD/Pcs) by Regions (2012-2017)
Table Asia Pacific Live Attenuated Vaccine Sales (K Pcs) by Regions (2012-2017)
Table Asia Pacific Live Attenuated Vaccine Revenue (Million USD) by Regions (2012-2017)
Table Top Companies of Asia Pacific Live Attenuated Vaccine Business Strategy, Channel and Performance List
Figure Asia Pacific Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Table Europe Live Attenuated Vaccine Sales (K Pcs) by Regions (2012-2017)
Table Europe Live Attenuated Vaccine Revenue (Million USD) by Regions (2012-2017)
Table Top Companies of Europe Live Attenuated Vaccine Business Strategy, Channel and Performance List
Figure Europe Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Table North America Live Attenuated Vaccine Sales (K Pcs) by Regions (2012-2017)
Table North America Live Attenuated Vaccine Revenue (Million USD) by Regions (2012-2017)
Table Top Companies of North America Live Attenuated Vaccine Business Strategy, Channel and Performance List
Figure North America Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Table Latin America Live Attenuated Vaccine Sales (K Pcs) by Regions (2012-2017)
Table Latin America Live Attenuated Vaccine Revenue (Million USD) by Regions (2012-2017)
Table Top Companies of Latin America Live Attenuated Vaccine Business Strategy, Channel and Performance List
Figure Latin America Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Table Southeast Asia Live Attenuated Vaccine Sales (K Pcs) by Regions (2012-2017)
Table Southeast Asia Live Attenuated Vaccine Revenue (Million USD) by Regions (2012-2017)
Table Top Companies of Southeast Asia Live Attenuated Vaccine Business Strategy, Channel and Performance List
Figure Southeast Asia Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Table Middle East & Africa Live Attenuated Vaccine Sales (K Pcs) by Regions (2012-2017)
Table Middle East & Africa Live Attenuated Vaccine Revenue (Million USD) by Regions (2012-2017)
Table Top Companies of Middle East & Africa Live Attenuated Vaccine Business Strategy, Channel and Performance List
Figure Middle East & Africa Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure South Africa Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Table China Live Attenuated Vaccine Sales Volume (K Pcs) by Key Players (2012-2017)
Table China Live Attenuated Vaccine Sales Volume Market Share by Key Players (2012-2017)
Figure China Live Attenuated Vaccine Sales Volume Market Share by Key Players 2016
Figure China Live Attenuated Vaccine Sales Volume Market Share by Key Players 2017
Table China Live Attenuated Vaccine Revenue (Million USD) by Key Players (2012-2017)
Table China Live Attenuated Vaccine Revenue Market Share by Key Players (2012-2017)
Figure China Live Attenuated Vaccine Revenue Market Share by Key Players 2016
Figure China Live Attenuated Vaccine Revenue Market Share by Key Players 2017
Table China Top Brands Key Product Model and Market Performance
Table China Top Brands Key Target Consumers and Market Performance
Table Astellas Pharma (Japan) Company Details and Competitors
Table Astellas Pharma (Japan) Key Live Attenuated Vaccine Models and Performance
Table Astellas Pharma (Japan) Live Attenuated Vaccine Business SWOT Analysis and Forecast
Table Astellas Pharma (Japan) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Astellas Pharma (Japan) Live Attenuated Vaccine Sales(K Pcs) and Growth Rate (%)(2012-2017)
Figure Astellas Pharma (Japan) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2017)
Figure Astellas Pharma (Japan) Live Attenuated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Astellas Pharma (Japan) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2017)
Table CSL Limited (Australia) Company Details and Competitors
Table CSL Limited (Australia) Key Live Attenuated Vaccine Models and Performance
Table CSL Limited (Australia) Live Attenuated Vaccine Business SWOT Analysis and Forecast
Table CSL Limited (Australia) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure CSL Limited (Australia) Live Attenuated Vaccine Sales(K Pcs) and Growth Rate (%)(2012-2017)
Figure CSL Limited (Australia) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2017)
Figure CSL Limited (Australia) Live Attenuated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure CSL Limited (Australia) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2017)
Table Emergent BioSolutions (U.S.) Company Details and Competitors
Table Emergent BioSolutions (U.S.) Key Live Attenuated Vaccine Models and Performance
Table Emergent BioSolutions (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
Table Emergent BioSolutions (U.S.) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Emergent BioSolutions (U.S.) Live Attenuated Vaccine Sales(K Pcs) and Growth Rate (%)(2012-2017)
Figure Emergent BioSolutions (U.S.) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2017)
Figure Emergent BioSolutions (U.S.) Live Attenuated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Emergent BioSolutions (U.S.) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2017)
Table GlaxoSmithKline (U.K.) Company Details and Competitors
Table GlaxoSmithKline (U.K.) Key Live Attenuated Vaccine Models and Performance
Table GlaxoSmithKline (U.K.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
Table GlaxoSmithKline (U.K.) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure GlaxoSmithKline (U.K.) Live Attenuated Vaccine Sales(K Pcs) and Growth Rate (%)(2012-2017)
Figure GlaxoSmithKline (U.K.) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2017)
Figure GlaxoSmithKline (U.K.) Live Attenuated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure GlaxoSmithKline (U.K.) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2017)
Table Johnson & Johnson (U.S.) Company Details and Competitors
Table Johnson & Johnson (U.S.) Key Live Attenuated Vaccine Models and Performance
Table Johnson & Johnson (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
Table Johnson & Johnson (U.S.) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Johnson & Johnson (U.S.) Live Attenuated Vaccine Sales(K Pcs) and Growth Rate (%)(2012-2017)
Figure Johnson & Johnson (U.S.) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2017)
Figure Johnson & Johnson (U.S.) Live Attenuated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Johnson & Johnson (U.S.) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2017)
Table MedImmune (U.S.) Company Details and Competitors
Table MedImmune (U.S.) Key Live Attenuated Vaccine Models and Performance
Table MedImmune (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
Table MedImmune (U.S.) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure MedImmune (U.S.) Live Attenuated Vaccine Sales(K Pcs) and Growth Rate (%)(2012-2017)
Figure MedImmune (U.S.) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2017)
Figure MedImmune (U.S.) Live Attenuated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure MedImmune (U.S.) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2017)
Table Merck & Co (U.S.) Company Details and Competitors
Table Merck & Co (U.S.) Key Live Attenuated Vaccine Models and Performance
Table Merck & Co (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
Table Merck & Co (U.S.) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Merck & Co (U.S.) Live Attenuated Vaccine Sales(K Pcs) and Growth Rate (%)(2012-2017)
Figure Merck & Co (U.S.) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2017)
Figure Merck & Co (U.S.) Live Attenuated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Merck & Co (U.S.) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2017)
Table Pfizer (U.S.) Company Details and Competitors
Table Pfizer (U.S.) Key Live Attenuated Vaccine Models and Performance
Table Pfizer (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
Table Pfizer (U.S.) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Pfizer (U.S.) Live Attenuated Vaccine Sales(K Pcs) and Growth Rate (%)(2012-2017)
Figure Pfizer (U.S.) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2017)
Figure Pfizer (U.S.) Live Attenuated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Pfizer (U.S.) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2017)
Table Sanofi Pasteur (France) Company Details and Competitors
Table Sanofi Pasteur (France) Key Live Attenuated Vaccine Models and Performance
Table Sanofi Pasteur (France) Live Attenuated Vaccine Business SWOT Analysis and Forecast
Table Sanofi Pasteur (France) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Sanofi Pasteur (France) Live Attenuated Vaccine Sales(K Pcs) and Growth Rate (%)(2012-2017)
Figure Sanofi Pasteur (France) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2017)
Figure Sanofi Pasteur (France) Live Attenuated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Sanofi Pasteur (France) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2017)
Table Serum Institute of India Pvt (India) Company Details and Competitors
Table Serum Institute of India Pvt (India) Key Live Attenuated Vaccine Models and Performance
Table Serum Institute of India Pvt (India) Live Attenuated Vaccine Business SWOT Analysis and Forecast
Table Serum Institute of India Pvt (India) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Serum Institute of India Pvt (India) Live Attenuated Vaccine Sales(K Pcs) and Growth Rate (%)(2012-2017)
Figure Serum Institute of India Pvt (India) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2017)
Figure Serum Institute of India Pvt (India) Live Attenuated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Serum Institute of India Pvt (India) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2017)
Table China Live Attenuated Vaccine Sales (K Pcs) by Consumer (2012-2017)
Figure China Live Attenuated Vaccine Sales Market Share by Consumer (2012-2017)
Figure China Live Attenuated Vaccine Sales Market Share by Consumer in 2016
Table Global Live Attenuated Vaccine Sales (K Pcs) by Consumer (2012-2017)
Figure Global Live Attenuated Vaccine Sales Market Share by Consumer (2012-2017)
Figure Global Live Attenuated Vaccine Sales Market Share by Consumer in 2016
Figure China Hospital Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Global Hospital Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Medical Center Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Global Medical Center Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Others Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Global Others Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure China Live Attenuated Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Live Attenuated Vaccine Price (USD/Pcs) Trend Forecast (2017-2022)
Figure Global Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure Global Live Attenuated Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Live Attenuated Vaccine Price (USD/Pcs) Trend Forecast (2017-2022)
Table China Live Attenuated Vaccine Sales (K Pcs) Forecast by Type (2017-2022)
Table Global Live Attenuated Vaccine Sales (K Pcs) Forecast by Type (2017-2022)
Figure China Live Attenuated Vaccine Sales (K Pcs) Forecast by Type (2017-2022)
Figure Global Live Attenuated Vaccine Sales (K Pcs) Forecast by Type (2017-2022)
Figure China Live Attenuated Vaccine Sales Volume Market Share Forecast by Type in 2017
Figure Global Live Attenuated Vaccine Sales Volume Market Share Forecast by Type in 2017
Table China Live Attenuated Vaccine Sales (K Pcs) Forecast by Application (2017-2022)
Table Global Live Attenuated Vaccine Sales (K Pcs) Forecast by Application (2017-2022)
Figure China Live Attenuated Vaccine Sales Volume Market Share Forecast by Application (2017-2022)
Figure Global Live Attenuated Vaccine Sales Volume Market Share Forecast by Application (2017-2022)
Figure China Live Attenuated Vaccine Sales Volume Market Share Forecast by Application in 2017
Figure Global Live Attenuated Vaccine Sales Volume Market Share Forecast by Application in 2017
Table China Live Attenuated Vaccine Sales (K Pcs) Forecast by Regions (2017-2022)
Table Global Live Attenuated Vaccine Sales Volume Share Forecast by Regions (2017-2022)
Table China Live Attenuated Vaccine Sales Volume Share Forecast by Regions (2017-2022)
Table Global Live Attenuated Vaccine Sales (K Pcs) Forecast by Regions (2017-2022)
Figure China Live Attenuated Vaccine Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Live Attenuated Vaccine Sales Volume Share Forecast by Regions (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *